PCT stock icon

PureCycle Technologies

12.87 USD
-0.15
1.15%
At close Nov 1, 4:00 PM EDT
After hours
12.94
+0.07
0.54%
1 day
-1.15%
5 days
-10.00%
1 month
46.08%
3 months
72.75%
6 months
175.59%
Year to date
243.20%
1 year
207.89%
5 years
-60.63%
 

About: PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin. The proprietary process removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.

Employees: 146

0
Funds holding %
of 6,759 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

93% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 40

54% more call options, than puts

Call options by funds: $29.3M | Put options by funds: $19M

25% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 24

8.31% more ownership

Funds ownership: 62.66% [Q1] → 70.97% (+8.31%) [Q2]

8% more capital invested

Capital invested by funds: $637M [Q1] → $688M (+$50.9M) [Q2]

3% more funds holding

Funds holding: 178 [Q1] → 184 (+6) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q1] → 5 (+0) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$6
53%
downside
Avg. target
$9.33
27%
downside
High target
$14
9%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Cantor Fitzgerald
Andres Sheppard
64% 1-year accuracy
66 / 103 met price target
9%upside
$14
Overweight
Initiated
18 Oct 2024
Stifel
Michael Hoffman
63% 1-year accuracy
17 / 27 met price target
38%downside
$8
Buy
Maintained
12 Aug 2024
Craig-Hallum
Eric Stine
42% 1-year accuracy
8 / 19 met price target
53%downside
$6
Hold
Maintained
9 Aug 2024

Financial journalist opinion

Based on 5 articles about PCT published over the past 30 days

Charts implemented using Lightweight Charts™